Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Eisenhauer

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2017
Real-world evidence in the treatment of ovarian cancerE A Eisenhauer
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
New cytotoxics and non-cytotoxics in epithelial ovarian cancerE. A. Eisenhauer
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
Optimal assessment of response in ovarian cancerE A Eisenhauer
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
High-dose chemotherapy: is it standard management for any common solid tumor?M MacNeil, E A Eisenhauer
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
An overview of phase II studies of docetaxel in patients with metastatic breast cancerE A Eisenhauer, M Trudeau
British Journal of Cancer|August 1, 1996
Current perspectives on camptothecins in cancer treatmentJ Dancey, E A Eisenhauer
Current Opinion in Oncology|September 1, 1996
New drugs in gynecologic oncologyE A Eisenhauer, J B Vermorken
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Systemic treatment policies in ovarian cancer: the next 10 yearsJ J Biagi, E A Eisenhauer
Drugs|February 17, 1998
The taxoids. Comparative clinical pharmacology and therapeutic potentialE A Eisenhauer, J B Vermorken
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Phase I trial design: are new methodologies being put into practice?S F Dent, E A Eisenhauer
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2017
Real-world evidence in the treatment of ovarian cancerE A Eisenhauer
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
New cytotoxics and non-cytotoxics in epithelial ovarian cancerE. A. Eisenhauer
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
Optimal assessment of response in ovarian cancerE A Eisenhauer
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 1999
High-dose chemotherapy: is it standard management for any common solid tumor?M MacNeil, E A Eisenhauer
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
An overview of phase II studies of docetaxel in patients with metastatic breast cancerE A Eisenhauer, M Trudeau
British Journal of Cancer|August 1, 1996
Current perspectives on camptothecins in cancer treatmentJ Dancey, E A Eisenhauer
Current Opinion in Oncology|September 1, 1996
New drugs in gynecologic oncologyE A Eisenhauer, J B Vermorken
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 6, 2003
Systemic treatment policies in ovarian cancer: the next 10 yearsJ J Biagi, E A Eisenhauer
Drugs|February 17, 1998
The taxoids. Comparative clinical pharmacology and therapeutic potentialE A Eisenhauer, J B Vermorken
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Phase I trial design: are new methodologies being put into practice?S F Dent, E A Eisenhauer
Pageof 8